Table 1.
Therapy | Trade Name | Approved for | Patient Population | Approval Date |
---|---|---|---|---|
Tisagenlecleucel | Kymriah | Large B-cell lymphomas | Adult | 1 May 2018 |
B-cell precursor acute lymphoblastic leukemia | Up to 25 years of age | 30 August 2017 | ||
Axicabtagene ciloleucel | Yescarta | Large B-cell lymphomas | Adult | 18 October 2017 |